Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow....

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Chronic Myelocytic Leukemia CML

Chronic myelocytic leukemia is the resulting disease when neutrophil, basophil, eosinophil, and monocyte progenitors become cancerous. It is usually caused by the presence of the Philadelphia chromo...

New T-cell therapy cures leukemia in 2 children

Two children with an aggressive form of childhood leukemia had a complete remission of their disease—showing no evidence of cancer cells in their bodies—after treatment with a novel cell therapy t...

Rare leukemia-causing protein discovered

Researchers have discovered a new gene target for leukemia therapy. Researchers found that by inhibiting in animal models the protein Vav3, which controls cell signaling, the development of this leuke...

Novel Human Monoclonal Antibody Cures Leukemia in Mouse Model

A novel monoclonal antibody that binds to the intracellular WT1 protein, which is expressed in many types of cancer...

Ideal Cures say new excipient tech can cut 3 months off costing development

Ideal Cures has launched a ‘ready-to-use’ ER tablet coating designed to help mid-sized Pharmas cut costs and save time.

Ariad’s Leukemia Drug Iclusig Sails Through FDA In Less Than 3 Months

Ponatinib received accelerated approval for use in chronic myeloid leukemia and acute lymphoblastic leukemia patients who are resistant or intolerant to prior therapy with tyrosine kinase inhibitors.

Ariad Pharma files for approval of leukemia drug

Ariad Pharmaceuticals Inc. said Monday it filed for U.S. marketing approval of leukemia drug ponatinib.Ariad said it asked the Food and Drug Administration to approve ponatinib as a treatment for chr...

Quest for Cures: The Leukemia & Lymphoma Society Seeks to Fund Three Critical Areas of Blood Cancer Research

WHITE PLAINS, N.Y., Feb. 28, 2013 /PRNewswire/ -- Medical innovation and sustained research investment are dramatically transforming the landscape in blood cancers. To that end, The Leukemia &...

Researchers Create Synthetic Stool That Cures C. Diff

Canadian scientists have created an artificial stool that cures bouts of Clostridium difficile (C. diff). This toxin-producing bacterium causes serious intestinal infections responsible for the deaths...

Treatment and Prevention of Alcohol Hangover.

The search for alcohol hangover cures is as old as alcohol itself. Many cures and prophylactic agents are available, but scientific evidence for their effectiveness is generally lacking. This review s...

A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance.

The t(4;9)(q11;q33) fuses CEP110 to KIT in a case of acute myeloid leukemia.

Relative fitness of hematopoietic progenitors influences leukemia progression.